José Accini - Concepedia

Author

José Accini

Also Known As

Anum Abbas, Camilo Arana, J.G. Zhao, J.L. Accini, Jose Accini, Jose L Accini, Jose L. Accini, Jose Luis Accini, José Accini, José L. Accini

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Universidad De Santander Population Health Research Institute University of Cape Town Hamilton Health Sciences St. Michael's Hospital

About

José Accini is an author at Universidad De Santander specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	3.8K
2	Public Health	2	2	3.2K
3	Diabetes	2	2	3.4K
4	Health Policy	2	2	3.2K
5	Epidemiology	1	1	368

José Accini

Publications

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease Salim Yusuf, Eva Lonn, Prem Pais, New England Journal of Medicine HypertensionCardiovascular EpidemiologyCardiovascular DiseaseHealth PolicyBlood Pressure	2016	368
Fatal cases of Chikungunya virus infection in Colombia: Diagnostic and treatment challenges Juan M. de la Hoz, Brayan Bayona, Samir Viloria, Journal of Clinical Virology Chikungunya Virus InfectionVirus EpidemiologyTreatment ChallengesViral DiagnosticsVirology	2015	67
Risk Factors for Preeclampsia in Women from Colombia: A Case-Control Study Laura M. Reyes, Ronald G. García, Silvia López Ruiz, PLoS ONE	2012	50
Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome Patricio López‐Jaramillo, Eduardo Costa Duarte Barbosa, Dora I. Molina, Journal of Hypertension	2019	42
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, The Lancet	2025	29
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh, The Lancet Respiratory Medicine VaccinationVaccine SafetyVaccine DevelopmentPhase 3Immunology	2023	23
Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial Sady Alpizar, José Accini, Duane C. Anderson, Journal of Infection	2023	19
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler, The Lancet	2025	14

Page 1